Advertisement
UK markets open in 5 hours 6 minutes

  • NIKKEI 225

    37,945.47
    -514.61 (-1.34%)
     

  • HANG SENG

    17,149.72
    -51.55 (-0.30%)
     

  • CRUDE OIL

    82.64
    -0.17 (-0.21%)
     

  • GOLD FUTURES

    2,331.10
    -7.30 (-0.31%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,564.98
    -2,048.19 (-3.82%)
     

  • CMC Crypto 200

    1,394.38
    -29.72 (-2.08%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Pharmacy chains sue Bausch Health, other drugmakers for overcharging for diabetes drug

Reuters

(Reuters) - Three pharmacy chains, including Walgreens Boots Alliance <WBA.O>, have filed a lawsuit against drugmakers Bausch Health Inc <BHC.TO>, Assertio Therapeutics <ASRT.O> and Lupin Ltd <LUPN.NS>, seeking damages for overcharging for Bausch's diabetes drug Glumetza.

The lawsuit, filed on Monday, alleges that Assertio and Lupin struck a deal with units of Bausch to delay the entry of their generic versions of Glumetza and allowed the companies to "maintain a monopoly" in the sale of the branded drug and its generic copies.

Bausch, Assertio and Lupin did not immediately respond to Reuters' request for comment.

Albertson Companies Inc <ABS.N> and Kroger Inc <KR.N> were among the other defendants.

(Reporting by Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)